Closed-End Fund Advisors Inc. Investment Activity Q2 2026
This quarter, Closed-End Fund Advisors Inc. significantly increased its holdings in muni funds and credit-oriented ETFs while reducing exposure to certain other securities.

As of June 30th, 2026, Closed-End Fund Advisors Inc., a closed-end fund manager, demonstrated active investment strategies through notable changes in its portfolio. The firm's holdings saw significant shifts during the quarter, with both substantial purchases and strategic sales observed across various sectors.
The investor showed strong buying interest in fixed-income related securities this period. Notable increases included ABERDEEN MUN INCOME FD (MFM), which experienced a massive 69.6% share growth, followed by significant expansions in holdings of PIMCO NEW YORK MUN FD II (PNI) and NUVEEN MUN HIGH INCOME OPPOR (NMZ). Additionally, the firm bolstered positions in other funds like KAYNE ANDERSON BDC INC (KBDC) and HERCULES CAPITAL INC (HTGC), indicating a continued focus on credit opportunities, private capital investments, and potentially distressed assets.
The portfolio also reflected strategic adjustments in other areas. The investor increased its stake in GUGGENHEIM ACTIVE ALLOC FD (GUG) by 24.47%, suggesting confidence in active allocation strategies, and similarly boosted holdings of PUTNAM ETF TRUST (PBDC) by a substantial 70.51%. These actions point towards an investor comfortable with dynamic portfolio management within the Financial Services sector.
Conversely, Closed-End Fund Advisors Inc. also made significant reductions in certain holdings during Q2 2026. The most pronounced sell was observed in NEUBERGER R/EST SECS INC FD (XNROX), where shares decreased by a steep 69.13%. Another notable exit involved FLAHERTY & CRUMRIN PFD & INM (XFFCX), which saw its holdings drop significantly by -58.24%.
Furthermore, the investor scaled back positions in other funds such as CARLYLE SECURED LENDING INC (CGBD), which experienced a 20.94% reduction (-20681 shares), and ARROWMARK FINANCIAL CORP (BANX) with an 8.3% decrease in allocation (-21.67%). These exits, alongside the disclosed purchases, highlight a focused approach to managing risk and optimizing returns.